{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T10:21:02Z","timestamp":1787739662098,"version":"build-2784847793"},"update-to":[{"DOI":"10.1371\/journal.pntd.0009566","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2021,8,24]],"date-time":"2021-08-24T00:00:00Z","timestamp":1629763200000}}],"reference-count":39,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2021,8,12]],"date-time":"2021-08-12T00:00:00Z","timestamp":1628726400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP1195609"],"award-info":[{"award-number":["OPP1195609"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Faucett Catalyst Fund"},{"DOI":"10.13039\/100018269","name":"Shaffer Family Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100018269","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000038","name":"U.S. Food and Drug Administration","doi-asserted-by":"publisher","award":["HHSF223201610018C"],"award-info":[{"award-number":["HHSF223201610018C"]}],"id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Background<\/jats:title>\n<jats:p>Ebola virus (EBOV) is a zoonotic filovirus spread through exposure to infected bodily fluids of a human or animal. Though EBOV is capable of causing severe disease, referred to as Ebola Virus Disease (EVD), individuals who have never been diagnosed with confirmed, probable or suspected EVD can have detectable EBOV antigen-specific antibodies in their blood. This study aims to identify risk factors associated with detectable antibody levels in the absence of an EVD diagnosis.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Methodology<\/jats:title>\n<jats:p>Data was collected from September 2015 to August 2017 from 1,366 consenting individuals across four study sites in the DRC (Boende, Kabondo-Dianda, Kikwit, and Yambuku). Seroreactivity was determined to EBOV GP IgG using Zaire Ebola Virus Glycoprotein (EBOV GP antigen) ELISA kits (Alpha Diagnostic International, Inc.) in Kinshasa, DRC; any result above 4.7 units\/mL was considered seroreactive. Among the respondents, 113 (8.3%) were considered seroreactive. Several zoonotic exposures were associated with EBOV seroreactivity after controlling for age, sex, healthcare worker status, location, and history of contact with an EVD case, namely: ever having contact with bats, ever having contact with rodents, and ever eating non-human primate meat. Contact with monkeys or non-human primates was not associated with seroreactivity.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Conclusions<\/jats:title>\n<jats:p>This analysis suggests that some zoonotic exposures that have been linked to EVD outbreaks can also be associated with EBOV GP seroreactivity in the absence of diagnosed EVD. Future investigations should seek to clarify the relationships between zoonotic exposures, seroreactivity, asymptomatic infection, and EVD.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pntd.0009566","type":"journal-article","created":{"date-parts":[[2021,8,12]],"date-time":"2021-08-12T19:18:52Z","timestamp":1628795932000},"page":"e0009566","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":13,"title":["Zoonotic risk factors associated with seroprevalence of Ebola virus GP antibodies in the absence of diagnosed Ebola virus disease in the Democratic Republic of Congo"],"prefix":"10.1371","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5972-1249","authenticated-orcid":true,"given":"Anna","family":"Bratcher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1770-6304","authenticated-orcid":true,"given":"Nicole A.","family":"Hoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4631-9696","authenticated-orcid":true,"given":"Reena H.","family":"Doshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3217-2435","authenticated-orcid":true,"given":"Adva","family":"Gadoth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3892-2655","authenticated-orcid":true,"given":"Megan","family":"Halbrook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9312-9345","authenticated-orcid":true,"given":"Patrick","family":"Mukadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamy","family":"Musene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benoit","family":"Ilunga-Kebela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0145-9193","authenticated-orcid":true,"given":"D\u2019Andre","family":"Spencer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1216-7134","authenticated-orcid":true,"given":"Matthew S.","family":"Bramble","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2537-0273","authenticated-orcid":true,"given":"David","family":"McIlwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7616-0321","authenticated-orcid":true,"given":"J. Daniel","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6836-8704","authenticated-orcid":true,"given":"Daniel","family":"Mukadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Placide Mbala","family":"Kingebeni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve","family":"Ahuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emile","family":"Okitolonda-Wemakoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Jacques","family":"Muyembe-Tamfum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0662-9067","authenticated-orcid":true,"given":"Anne W.","family":"Rimoin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2021,8,12]]},"reference":[{"key":"pntd.0009566.ref001","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1056\/NEJMra1901594","article-title":"Ebola","volume":"382","author":"H Feldmann","year":"2020","journal-title":"N Engl J Med"},{"key":"pntd.0009566.ref002","unstructured":"Genus: Ebolavirus\u2014Filoviridae\u2014Negative-sense RNA Viruses\u2014ICTV [Internet]. [cited 21 Feb 2021]. Available: https:\/\/talk.ictvonline.org\/ictv-reports\/ictv_online_report\/negative-sense-rna-viruses\/w\/filoviridae\/1086\/genus-ebolavirus"},{"key":"pntd.0009566.ref003","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0140-6736(10)60667-8","article-title":"Ebola haemorrhagic fever","volume":"377","author":"H Feldmann","year":"2011","journal-title":"Lancet. Elsevier"},{"key":"pntd.0009566.ref004","doi-asserted-by":"crossref","unstructured":"Leroy EM,Epelboin A, Mondonge V, Pourrut X, Gonzalez JP, Muyembe-Tamfum JJ, et al. Human ebola outbreak resulting from direct exposure to fruit bats in Luebo, Democratic Republic of Congo, 2007. Vector-Borne Zoonotic Dis. Mary Ann Liebert, Inc. 140 Huguenot Street, 3rd Floor New Rochelle, NY 10801 USA; 2009;9: 723\u2013728. doi: 10.1089\/vbz.2008.0167","DOI":"10.1089\/vbz.2008.0167"},{"key":"pntd.0009566.ref005","first-page":"408","volume-title":"Trends in Microbiology","author":"A Groseth","year":"2007"},{"key":"pntd.0009566.ref006","doi-asserted-by":"crossref","first-page":"17","DOI":"10.15252\/emmm.201404792","article-title":"Investigating the zoonotic origin of the West African Ebola epidemic","volume":"7","author":"A Mar\u00ed Sa\u00e9z","year":"2015","journal-title":"EMBO Mol Med"},{"key":"pntd.0009566.ref007","unstructured":"Transmission | Ebola Hemorrhagic Fever | CDC [Internet]. [cited 6 Jul 2020]. Available: https:\/\/www.cdc.gov\/vhf\/ebola\/transmission\/index.html"},{"key":"pntd.0009566.ref008","first-page":"1005","volume-title":"Microbes and Infection","author":"X Pourrut","year":"2005"},{"key":"pntd.0009566.ref009","doi-asserted-by":"crossref","first-page":"S177","DOI":"10.1093\/infdis\/jiw254","article-title":"Ebola Virus Shedding and Transmission: Review of Current Evidence","volume":"214","author":"P Vetter","year":"2016","journal-title":"J Infect Dis"},{"key":"pntd.0009566.ref010","doi-asserted-by":"crossref","first-page":"e0007428","DOI":"10.1371\/journal.pntd.0007428","article-title":"Estimating undetected ebola spillovers","volume":"13","author":"EE Glennon","year":"2019","journal-title":"PLoS Negl Trop Dis"},{"key":"pntd.0009566.ref011","first-page":"1","volume-title":"Scientific Data","author":"H Bower","year":"2017"},{"key":"pntd.0009566.ref012","first-page":"3120","volume-title":"Journal of General Virology","author":"M Formella","year":"2016"},{"key":"pntd.0009566.ref013","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/0035-9203(93)90075-2","article-title":"Haemorrhagic fever virus activity in equatorial Africa: distribution and prevalence of filovirus reactive antibody in the Central African Republic","volume":"87","author":"ED Johnson","year":"1993","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"pntd.0009566.ref014","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.4269\/ajtmh.1983.32.1465","article-title":"Ebola virus infection in man: A serological and epidemiological survey in the Cameroons","volume":"32","author":"P Bouree","year":"1983","journal-title":"Am J Trop Med Hyg"},{"key":"pntd.0009566.ref015","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/0035-9203(93)90077-4","article-title":"Filovirus activity among selected ethnic groups inhabiting the tropical forest of equatorial Africa","volume":"87","author":"ED Johnson","year":"1993","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"pntd.0009566.ref016","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jir344","article-title":"Risk factors for zaire ebolavirus-specific IgG in rural gabonese populations","volume":"204","author":"D Nkoghe","year":"2011","journal-title":"J Infect Dis"},{"key":"pntd.0009566.ref017","article-title":"Serologic Evidence of Ebolavirus Infection in a Population With No History of Outbreaks in the Democratic Republic of the Congo","volume":"217","author":"S Mulangu","year":"2018","journal-title":"Ebolavirus Seroprevalence \u2022 JID"},{"key":"pntd.0009566.ref018","first-page":"e0005087","article-title":"Minimally Symptomatic Infection in an Ebola \u2018Hotspot\u2019: A Cross-Sectional Serosurvey","volume":"10","author":"ET Richardson","year":"2016","journal-title":"Public Library of Science"},{"key":"pntd.0009566.ref019","doi-asserted-by":"crossref","first-page":"955","DOI":"10.3201\/eid2505.181666","article-title":"Bombali virus in mops condylurus bat, kenya","volume":"25","author":"KM Forbes","year":"2019","journal-title":"Emerg Infect Dis"},{"key":"pntd.0009566.ref020","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1038\/s41564-018-0227-2","article-title":"The discovery of Bombali virus adds further support for bats as hosts of ebolaviruses","volume":"3","author":"T Goldstein","year":"2018","journal-title":"Nat Microbiol"},{"key":"pntd.0009566.ref021","doi-asserted-by":"crossref","first-page":"15889","DOI":"10.1073\/pnas.2237038100","article-title":"Ebola virus-like particles protect from lethal Ebola virus infection","volume":"100","author":"KL Warfield","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"pntd.0009566.ref022","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0140-6736(16)32621-6","article-title":"Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola \u00c7a Suffit!).","volume":"389","author":"AM Henao-Restrepo","year":"2017","journal-title":"Lancet"},{"key":"pntd.0009566.ref023","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1056\/NEJMoa1614067","article-title":"Phase 2 Placebo-Controlled Trial of Two Vaccines to Prevent Ebola in Liberia","volume":"377","author":"SB Kennedy","year":"2017","journal-title":"N Engl J Med"},{"key":"pntd.0009566.ref024","doi-asserted-by":"crossref","first-page":"20160303","DOI":"10.1098\/rstb.2016.0303","article-title":"Evaluating the frequency of asymptomatic Ebola virus infection","volume":"372","author":"P Mbala","year":"2017","journal-title":"Philos Trans R Soc B Biol Sci"},{"key":"pntd.0009566.ref025","doi-asserted-by":"crossref","first-page":"S102","DOI":"10.1086\/514309","article-title":"Prevalence of IgG Antibodies to Ebola Virus in Individuals during an Ebola Outbreak, Democratic Republic of the Congo, 1995","volume":"179","author":"KM Busico","year":"1999","journal-title":"J Infect Dis"},{"key":"pntd.0009566.ref026","doi-asserted-by":"crossref","first-page":"e0003833","DOI":"10.1371\/journal.pntd.0003833","article-title":"Risk Factors Associated with Ebola and Marburg Viruses Seroprevalence in Blood Donors in the Republic of Congo","volume":"9","author":"N Moyen","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"pntd.0009566.ref027","doi-asserted-by":"crossref","first-page":"e9126","DOI":"10.1371\/journal.pone.0009126","article-title":"High Prevalence of Both Humoral and Cellular Immunity to Zaire ebolavirus among Rural Populations in Gabon","volume":"5","author":"P Becquart","year":"2010","journal-title":"PLoS One"},{"key":"pntd.0009566.ref028","unstructured":"Centers for Disease Control and Prevention (CDC). Years of Ebola Virus Disease Outbreaks [Internet]. [cited 28 Jan 2020]. Available: https:\/\/www.cdc.gov\/vhf\/ebola\/history\/chronology.html"},{"key":"pntd.0009566.ref029","first-page":"1","article-title":"Cost effectiveness of measles eradication Final Report","volume":"528","author":"D Walker","year":"2015","journal-title":"Bull World Health Organ"},{"key":"pntd.0009566.ref030","article-title":"Risk Factors for Ebola Exposure in Health Care Workers in Boende, Tshuapa Province, Democratic Republic of the Congo","author":"RH Doshi","year":"2020","journal-title":"J Infect Dis"},{"key":"pntd.0009566.ref031","article-title":"Serologic Markers for Ebolavirus Among Healthcare Workers in the Democratic Republic of the Congo","volume":"517","author":"NA Hoff","year":"2019","journal-title":"J Infect Dis EBOV Serol Markers Among HCWs DRC \u2022 JID"},{"key":"pntd.0009566.ref032","author":"AW Rimoin","journal-title":"Ebola Virus Neutralizing Antibodies Detectable in Survivors of the Yambuku, Zaire Outbreak 40 Years after Infection"},{"key":"pntd.0009566.ref033","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1111\/j.1553-2712.2011.01185.x","article-title":"Logistic Regression: A Brief Primer","volume":"18","author":"JC Stoltzfus","year":"2011","journal-title":"Acad Emerg Med"},{"key":"pntd.0009566.ref034","doi-asserted-by":"crossref","first-page":"741","DOI":"10.3201\/eid2005.130539","article-title":"Bat flight and zoonotic viruses","volume":"20","author":"TJ O\u2019Shea","year":"2014","journal-title":"Emerg Infect Dis"},{"key":"pntd.0009566.ref035","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.tim.2014.12.004","article-title":"Bats as \u201cspecial\u201d reservoirs for emerging zoonotic pathogens","author":"CE Brook","year":"2015","journal-title":"Trends in Microbiology"},{"key":"pntd.0009566.ref036","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3389\/fimmu.2020.00026","article-title":"Novel Insights Into Immune Systems of Bats","author":"A Banerjee","year":"2020","journal-title":"Frontiers in Immunology"},{"key":"pntd.0009566.ref037","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.3201\/eid2207.160233","article-title":"Effective chemical inactivation of Ebola virus","volume":"22","author":"E Haddock","year":"2016","journal-title":"Emerg Infect Dis"},{"key":"pntd.0009566.ref038","first-page":"172","article-title":"Forest Ecosystems and Ebola.","volume":"93","author":"JM Morvan","year":"2000","journal-title":"Bull la Soc Pathol Exot"},{"key":"pntd.0009566.ref039","author":"NE Dean","year":"2016","journal-title":"Transmissibility and Pathogenicity of Ebola Virus: A Systematic Review and Meta-analysis of Household Secondary Attack Rate and Asymptomatic Infection"}],"updated-by":[{"DOI":"10.1371\/journal.pntd.0009566","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2021,8,24]],"date-time":"2021-08-24T00:00:00Z","timestamp":1629763200000}},{"DOI":"10.1371\/journal.pntd.0010465","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2022,5,18]],"date-time":"2022-05-18T00:00:00Z","timestamp":1652832000000}}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0009566","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,24]],"date-time":"2021-08-24T18:20:55Z","timestamp":1629829255000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0009566"}},"subtitle":[],"editor":[{"given":"Alexander","family":"Bukreyev","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2021,8,12]]},"references-count":39,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2021,8,12]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0009566","relation":{"new_version":[{"id-type":"doi","id":"10.1371\/journal.pntd.0009566","asserted-by":"object"}],"correction":[{"id-type":"doi","id":"10.1371\/journal.pntd.0010465","asserted-by":"object"}]},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,12]]}}}